Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 42 positions · Total reported value $1.22B · Top-10 concentration 66.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Cormorant Asset Management, LP disclosed 42 equity positions with a combined reported value of $1.22B. The filing implies a focused portfolio: its ten largest positions account for 66.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were MLTX ($331.87M), EWTX ($90.24M), BBIO ($69.14M). By sector, the heaviest allocations are Health Care 78.1%, Industrials 3.7%. Versus the prior quarter, allocation shifted toward Other (+1.0pp) and away from Health Care (-1.3pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q1 2025 were MTSR ($10.89M), KRRO ($6.62M), AARD ($6.01M).

Of the 2 positions fully exited versus the prior quarter, the largest were AVBP ($15.60M), SEPN ($12.82M), IBRX ($7.68M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • MTSR METSERA INC · $10.89M
  • KRRO KORRO BIO INC · $6.62M
  • AARD AARDVARK THERAPEUTICS INC · $6.01M
  • PLRX PLIANT THERAPEUTICS INC · $4.05M

Fully Exited (vs previous quarter)

  • AVBP ARRIVENT BIOPHARMA INC · prev qtr: $15.60M
  • SEPN SEPTERNA INC · prev qtr: $12.82M
  • IBRX IMMUNITYBIO INC · prev qtr: $7.68M
  • VYNE YARROW BIOSCIENCES INC · prev qtr: $4.67M
  • YMAB Y-MABS THERAPEUTICS INC · prev qtr: $3.33M
  • URGN UROGEN PHARMA LTD · prev qtr: $3.19M
  • OMER OMEROS CORP · prev qtr: $2.96M
  • VERV VERVE THERAPEUTICS INC · prev qtr: $1.97M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.1%
Other 18.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $331.87M 27.24%
27.24%
Hold
2 4.10M $90.24M 7.41%
7.41%
Add
3 2.00M $69.14M 5.68%
5.68%
Add
4 1.05M $68.88M 5.66%
5.66%
Reduce
5 1.75M $66.08M 5.42%
5.42%
Add
6 8.32M $45.12M 3.70%
3.70%
Hold
7 525.00K $40.05M 3.29%
3.29%
Reduce
8 1.06M $38.21M 3.14%
3.14%
Hold
9 2.91M $32.87M 2.70%
2.70%
Hold
10 2.26M $32.52M 2.67%
2.67%
Reduce
11 740.00K $31.15M 2.56%
2.56%
Hold
12 2.94M $29.50M 2.42%
2.42%
Hold
13 250.00K $29.16M 2.39%
2.39%
Reduce
14 1.47M $23.02M 1.89%
1.89%
Hold
15 2.01M $22.16M 1.82%
1.82%
Add
16 1.35M $21.11M 1.73%
1.73%
Reduce
17 400.00K $20.55M 1.69%
1.69%
Reduce
18 1.60M $20.13M 1.65%
1.65%
Add
19 600.00K $20.12M 1.65%
1.65%
Reduce
20 775.00K $18.98M 1.56%
1.56%
Hold
21 3.38M $13.76M 1.13%
1.13%
Add
22 2.13M $13.31M 1.09%
1.09%
Hold
23 2.15M $13.19M 1.08%
1.08%
Hold
24 2.38M $12.61M 1.03%
Form 4 · 1 →
1.03%
Hold
25 400.00K $11.81M 0.97%
0.97%
Reduce
26 400.00K $10.89M 0.89%
0.89%
New
27 2.32M $10.41M 0.85%
0.85%
Hold
28 2.63M $9.89M 0.81%
0.81%
Hold
29 150.00K $7.95M 0.65%
0.65%
Reduce
30 1.84M $7.90M 0.65%
0.65%
Hold
31 3.57M $7.61M 0.62%
0.62%
Hold
32 380.30K $6.62M 0.54%
0.54%
New
33 175.00K $6.61M 0.54%
0.54%
Reduce
34 800.19K $6.01M 0.49%
0.49%
New
35 700.00K $5.17M 0.42%
0.42%
Hold
36 250.00K $5.12M 0.42%
0.42%
Reduce
37 250.00K $4.92M 0.40%
0.40%
Hold
38 3.00M $4.05M 0.33%
0.33%
New
39 150.00K $4.05M 0.33%
0.33%
Reduce
40 603.03K $3.46M 0.28%
0.28%
Hold
41 254.16K $1.69M 0.14%
0.14%
Hold
42 10.00K $240.40K 0.02%
0.02%
Reduce

FAQ

What did Cormorant Asset Management, LP buy in 2025-Q1?

In its 2025-Q1 13F filing, Cormorant Asset Management, LP reported 42 equity positions worth $1.22B in aggregate; its largest disclosed positions were MLTX ($331.87M), EWTX ($90.24M), BBIO ($69.14M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $1.22B of long equity holdings across 42 positions as of 2025-Q1. Top-10 holdings account for 66.9% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →